UBS Keeps Buy on NVIDIA, $185 Price Target
- Rating
- Buy
- Price target
- $185
- Implied upside
- +65%
- vs $112.20 prior close
UBS analyst Timothy Arcuri reiterated a Buy rating and $185 price target on NVIDIA (NASDAQ: NVDA).
“NVDA announced the H20 will now require a license for shipment to China and other D5 countries (e.g. Russia and other US arms-embargo countries) and the company is also taking a $5.5B reserve.
Based on our discussions, this is effectively a ban.
While clearly reducing NVDA’s ability to beat and raise, this may be a clearing event for the stock if in exchange for committing to build $500B of AI infrastructure in the US over the next 4yrs, NVDA used this as concession to effectively kill the AI Diffusion Rule.
While we are making no changes to our current estimates, fully stripping H20 out of our numbers would drive ~$0.20 EPS impact.”
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
Tracking this call
Since this note+105% NVDA $112.20 → $230.48 (Oct 9) · target reached
This call✓ Target reached on Sep 30, 2025, 6 months after the note. Same target as this firm’s Apr 11, 2025 note, so it is scored there.
Firm track recordUBS: 72% of its 18 targets at least a year old were reached within 12 months (#14 of 20 firms); on NVIDIA, 5 of 5. Accuracy ranking →
More from UBS on NVIDIA
Other NVIDIA notes
Yorkville IvesBuy
Initiated coverage · Oct 7
$300
CantorBuy
Kept rating and price target · Oct 5
$350maintained
CantorBuy
Kept rating and price target · Oct 1
$350maintained
CitiBuy
Kept rating and price target · Sep 28
$315maintained
Goldman SachsBuy
Kept rating and price target · Sep 10
$300maintained